Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 198 publications
Specific F 1 ATP synthase inhibition delivers transient mitochondrial stress for selective targeting of acute myeloid leukemia.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
Journal: American journal of hematology
Published: June 25, 2026
Overall survival and long-term outcomes from the randomized, double-blind, placebo-controlled, phase III IMerge trial of imetelstat for lower-risk myelodysplastic syndromes.
Journal: Haematologica
Published: June 22, 2026
All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia.
Journal: The New England journal of medicine
Published: June 03, 2026
Mutation-specific impairment of TET2 and DNMT3A enzymatic activity predicts clonal hematopoiesis disease risk.
Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026
Spirocyclic β-lactone secondary metabolites modulate spliceosome function.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 31, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 27, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.
Journal: Blood cancer journal
Published: March 13, 2026
Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes.
Journal: Blood cancer journal
Published: February 03, 2026
Detection of clonal hematopoiesis of indeterminate potential via genome or exome sequencing underestimates disease associations.
Journal: The Journal of clinical investigation
Published: January 13, 2026
Last Updated: 09/26/2026